European Union · Question · QUESTION_WRITTEN
E-9-2021-005659
Full marketing authorisation for COVID-19 vaccines in the EU
Introduced
21 December 2021
Last action
4 March 2022 · Answer
Status
answered
Sponsors
Andreas GLÜCK
Subjects
Discovery layer
Source updated
4 March 2022
Records
Official question E-9-2021-005659 from European Union at European Parliament. Dated 21 December 2021. Status: answered.
Timeline
21 December 2021
Written question
Full marketing authorisation for COVID-19 vaccines in the EU
Source: QUESTION_WRITTEN
4 March 2022
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Full marketing authorisation for COVID-19 vaccines in the EU
QUESTION_WRITTEN · EN · 24 January 2022
Full marketing authorisation for COVID-19 vaccines in the EU
QUESTION_WRITTEN · EN · 24 January 2022
Full marketing authorisation for COVID-19 vaccines in the EU
QUESTION_WRITTEN · EN · 24 January 2022
Answer
QUESTION_WRITTEN_ANSWER · 4 March 2022
Uneingeschränkte Zulassung von COVID-19-Impfstoffen in der EU
QUESTION_WRITTEN · DE · 24 January 2022
Uneingeschränkte Zulassung von COVID-19-Impfstoffen in der EU
QUESTION_WRITTEN · DE · 24 January 2022
Uneingeschränkte Zulassung von COVID-19-Impfstoffen in der EU
QUESTION_WRITTEN · DE · 24 January 2022
Sponsors
- · COM · ADDRESSEE
- · EU_COMMISSION · ADDRESSEE
- Andreas GLÜCK · AUTHOR
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-9-2021-005659_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-9-2021-005659
- eu · E-9-2021-005659 · source updated 4 March 2022